Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT Study

Cancer-associated thrombosis (CT) is associated with a high risk of recurrent venous thromboembolic (VTE) events that require extended anticoagulation in patients with active cancer, putting them at risk of bleeding. The aim of the API-CAT study (NCT03692065) is to assess whether a reduced-dose regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahé, Isabelle, Agnelli, Giancarlo, Ay, Cihan, Bamias, Aristotelis, Becattini, Cecilia, Carrier, Marc, Chapelle, Céline, Cohen, Alexander T., Girard, Philippe, Huisman, Menno V., Klok, Frederikus A., López-Núñez, Juan J., Maraveyas, Anthony, Mayeur, Didier, Mir, Olivier, Monreal, Manuel, Righini, Marc, Samama, Charles M., Syrigos, Kostas, Szmit, Sebastian, Torbicki, Adam, Verhamme, Peter, Vicaut, Eric, Wang, Tzu-Fei, Meyer, Guy, Laporte, Silvy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113855/
https://www.ncbi.nlm.nih.gov/pubmed/34535037
http://dx.doi.org/10.1055/a-1647-9896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113855/
https://www.ncbi.nlm.nih.gov/pubmed/34535037
http://dx.doi.org/10.1055/a-1647-9896

Ejemplares similares